目次

Table of Contents

1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Competitive landscape

2 Introduction
2.1. What is this report about?
2.2. Who is the target reader?
2.3. How to use this report
2.4. Definitions

3 Global Generics
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in Asia-Pacific
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Generics in Europe
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis

7 Macroeconomic Indicators
7.1. Country data

8 Generics in France
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis

9 Macroeconomic Indicators
9.1. Country data

10 Generics in Germany
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis

11 Macroeconomic Indicators
11.1. Country data

12 Generics in Italy
12.1. Market Overview
12.2. Market Data
12.3. Market Segmentation
12.4. Market outlook
12.5. Five forces analysis

13 Macroeconomic Indicators
13.1. Country data

14 Generics in Japan
14.1. Market Overview
14.2. Market Data
14.3. Market Segmentation
14.4. Market outlook
14.5. Five forces analysis

15 Macroeconomic Indicators
15.1. Country data

16 Generics in Australia
16.1. Market Overview
16.2. Market Data
16.3. Market Segmentation
16.4. Market outlook
16.5. Five forces analysis

17 Macroeconomic Indicators
17.1. Country data

18 Generics in Canada
18.1. Market Overview
18.2. Market Data
18.3. Market Segmentation
18.4. Market outlook
18.5. Five forces analysis

19 Macroeconomic Indicators
19.1. Country data

20 Generics in China
20.1. Market Overview
20.2. Market Data
20.3. Market Segmentation
20.4. Market outlook
20.5. Five forces analysis

21 Macroeconomic Indicators
21.1. Country data

22 Generics in The Netherlands
22.1. Market Overview
22.2. Market Data
22.3. Market Segmentation
22.4. Market outlook
22.5. Five forces analysis

23 Macroeconomic Indicators
23.1. Country data

24 Generics in Spain
24.1. Market Overview
24.2. Market Data
24.3. Market Segmentation
24.4. Market outlook
24.5. Five forces analysis

25 Macroeconomic Indicators
25.1. Country data

26 Generics in The United Kingdom
26.1. Market Overview
26.2. Market Data
26.3. Market Segmentation
26.4. Market outlook
26.5. Five forces analysis

27 Macroeconomic Indicators
27.1. Country data

28 Generics in The United States
28.1. Market Overview
28.2. Market Data
28.3. Market Segmentation
28.4. Market outlook
28.5. Five forces analysis

29 Macroeconomic Indicators
29.1. Country data

30 Company Profiles
30.1. Teva Pharmaceutical Industries Limited
30.2. Pfizer Inc.
30.3. Sun Pharmaceutical Industries Ltd
30.4. Viatris Inc.
30.5. Sanofi SA
30.6. Les Laboratoires Servier
30.7. STADA Arzneimittel AG
30.8. Novartis AG
30.9. Daiichi Sankyo Co Ltd
30.10. Sawai Pharmaceutical Co Ltd
30.11. Lupin Ltd
30.12. Aspen Pharmacare Holdings Ltd
30.13. Apotex, Inc.
30.14. Grand Pharmaceutical Group Limited
30.15. Esteve Group

31 Appendix
31.1. Methodology
31.2. About MarketLine

List of Tables
Table 1: Global generics market value: $ million, 2017-22
Table 2: Global generics market volume: %, 2017-22
Table 3: Global generics market geography segmentation: $ million, 2022
Table 4: Global generics market value forecast: $ million, 2022-27
Table 5: Global generics market volume forecast: %, 2022-27
Table 6: Global size of population (million), 2018-22
Table 7: Global gdp (constant 2005 prices, $ billion), 2018-22
Table 8: Global gdp (current prices, $ billion), 2018-22
Table 9: Global inflation, 2018-22
Table 10: Global consumer price index (absolute), 2018-22
Table 11: Global exchange rate, 2018-22
Table 12: Asia-Pacific generics market value: $ million, 2017-22
Table 13: Asia-Pacific generics market volume: %, 2017-22
Table 14: Asia-Pacific generics market geography segmentation: $ million, 2022
Table 15: Asia-Pacific generics market value forecast: $ million, 2022-27
Table 16: Asia-Pacific generics market volume forecast: %, 2022-27
Table 17: Europe generics market value: $ million, 2017-22
Table 18: Europe generics market volume: %, 2017-22
Table 19: Europe generics market geography segmentation: $ million, 2022
Table 20: Europe generics market value forecast: $ million, 2022-27
Table 21: Europe generics market volume forecast: %, 2022-27
Table 22: Europe size of population (million), 2018-22
Table 23: Europe gdp (constant 2005 prices, $ billion), 2018-22
Table 24: Europe gdp (current prices, $ billion), 2018-22
Table 25: Europe inflation, 2018-22
Table 26: Europe consumer price index (absolute), 2018-22
Table 27: Europe exchange rate, 2018-22
Table 28: France generics market value: $ million, 2017-22
Table 29: France generics market volume: %, 2017-22
Table 30: France generics market geography segmentation: $ million, 2022
Table 31: France generics market value forecast: $ million, 2022-27
Table 32: France generics market volume forecast: %, 2022-27
Table 33: France size of population (million), 2018-22
Table 34: France gdp (constant 2005 prices, $ billion), 2018-22
Table 35: France gdp (current prices, $ billion), 2018-22
Table 36: France inflation, 2018-22
Table 37: France consumer price index (absolute), 2018-22
Table 38: France exchange rate, 2018-22
Table 39: Germany generics market value: $ million, 2017-22
Table 40: Germany generics market volume: %, 2017-22
Table 41: Germany generics market geography segmentation: $ million, 2022
Table 42: Germany generics market value forecast: $ million, 2022-27
Table 43: Germany generics market volume forecast: %, 2022-27
Table 44: Germany size of population (million), 2018-22
Table 45: Germany gdp (constant 2005 prices, $ billion), 2018-22
Table 46: Germany gdp (current prices, $ billion), 2018-22
Table 47: Germany inflation, 2018-22
Table 48: Germany consumer price index (absolute), 2018-22
Table 49: Germany exchange rate, 2018-22
Table 50: Italy generics market value: $ million, 2017-22
Table 51: Italy generics market volume: %, 2017-22
Table 52: Italy generics market geography segmentation: $ million, 2022
Table 53: Italy generics market value forecast: $ million, 2022-27
Table 54: Italy generics market volume forecast: %, 2022-27
Table 55: Italy size of population (million), 2018-22
Table 56: Italy gdp (constant 2005 prices, $ billion), 2018-22
Table 57: Italy gdp (current prices, $ billion), 2018-22
Table 58: Italy inflation, 2018-22
Table 59: Italy consumer price index (absolute), 2018-22
Table 60: Italy exchange rate, 2018-22
Table 61: Japan generics market value: $ million, 2017-22
Table 62: Japan generics market volume: %, 2017-22
Table 63: Japan generics market geography segmentation: $ million, 2022
Table 64: Japan generics market value forecast: $ million, 2022-27
Table 65: Japan generics market volume forecast: %, 2022-27
Table 66: Japan size of population (million), 2018-22
Table 67: Japan gdp (constant 2005 prices, $ billion), 2018-22
Table 68: Japan gdp (current prices, $ billion), 2018-22
Table 69: Japan inflation, 2018-22
Table 70: Japan consumer price index (absolute), 2018-22
Table 71: Japan exchange rate, 2018-22
Table 72: Australia generics market value: $ million, 2017-22
Table 73: Australia generics market volume: %, 2017-22
Table 74: Australia generics market geography segmentation: $ million, 2022
Table 75: Australia generics market value forecast: $ million, 2022-27
Table 76: Australia generics market volume forecast: %, 2022-27
Table 77: Australia size of population (million), 2018-22
Table 78: Australia gdp (constant 2005 prices, $ billion), 2018-22
Table 79: Australia gdp (current prices, $ billion), 2018-22
Table 80: Australia inflation, 2018-22
Table 81: Australia consumer price index (absolute), 2018-22
Table 82: Australia exchange rate, 2018-22
Table 83: Canada generics market value: $ million, 2017-22
Table 84: Canada generics market volume: %, 2017-22
Table 85: Canada generics market geography segmentation: $ million, 2022
Table 86: Canada generics market value forecast: $ million, 2022-27
Table 87: Canada generics market volume forecast: %, 2022-27
Table 88: Canada size of population (million), 2018-22
Table 89: Canada gdp (constant 2005 prices, $ billion), 2018-22
Table 90: Canada gdp (current prices, $ billion), 2018-22
Table 91: Canada inflation, 2018-22
Table 92: Canada consumer price index (absolute), 2018-22
Table 93: Canada exchange rate, 2018-22
Table 94: China generics market value: $ million, 2017-22
Table 95: China generics market volume: %, 2017-22
Table 96: China generics market geography segmentation: $ million, 2022
Table 97: China generics market value forecast: $ million, 2022-27
Table 98: China generics market volume forecast: %, 2022-27
Table 99: China size of population (million), 2018-22
Table 100: China gdp (constant 2005 prices, $ billion), 2018-22
Table 101: China gdp (current prices, $ billion), 2018-22
Table 102: China inflation, 2018-22
Table 103: China consumer price index (absolute), 2018-22
Table 104: China exchange rate, 2018-22
Table 105: Netherlands generics market value: $ million, 2017-22
Table 106: Netherlands generics market volume: %, 2017-22
Table 107: Netherlands generics market geography segmentation: $ million, 2022
Table 108: Netherlands generics market value forecast: $ million, 2022-27
Table 109: Netherlands generics market volume forecast: %, 2022-27
Table 110: Netherlands size of population (million), 2018-22
Table 111: Netherlands gdp (constant 2005 prices, $ billion), 2018-22
Table 112: Netherlands gdp (current prices, $ billion), 2018-22
Table 113: Netherlands inflation, 2018-22
Table 114: Netherlands consumer price index (absolute), 2018-22
Table 115: Netherlands exchange rate, 2018-22
Table 116: Spain generics market value: $ million, 2017-22
Table 117: Spain generics market volume: %, 2017-22
Table 118: Spain generics market geography segmentation: $ million, 2022
Table 119: Spain generics market value forecast: $ million, 2022-27
Table 120: Spain generics market volume forecast: %, 2022-27
Table 121: Spain size of population (million), 2018-22
Table 122: Spain gdp (constant 2005 prices, $ billion), 2018-22
Table 123: Spain gdp (current prices, $ billion), 2018-22
Table 124: Spain inflation, 2018-22
Table 125: Spain consumer price index (absolute), 2018-22
Table 126: Spain exchange rate, 2018-22
Table 127: United Kingdom generics market value: $ million, 2017-22
Table 128: United Kingdom generics market volume: %, 2017-22
Table 129: United Kingdom generics market geography segmentation: $ million, 2022
Table 130: United Kingdom generics market value forecast: $ million, 2022-27
Table 131: United Kingdom generics market volume forecast: %, 2022-27
Table 132: United Kingdom size of population (million), 2018-22
Table 133: United Kingdom gdp (constant 2005 prices, $ billion), 2018-22
Table 134: United Kingdom gdp (current prices, $ billion), 2018-22
Table 135: United Kingdom inflation, 2018-22
Table 136: United Kingdom consumer price index (absolute), 2018-22
Table 137: United Kingdom exchange rate, 2018-22
Table 138: United States generics market value: $ million, 2017-22
Table 139: United States generics market volume: %, 2017-22
Table 140: United States generics market geography segmentation: $ million, 2022
Table 141: United States generics market value forecast: $ million, 2022-27
Table 142: United States generics market volume forecast: %, 2022-27
Table 143: United States size of population (million), 2018-22
Table 144: United States gdp (constant 2005 prices, $ billion), 2018-22
Table 145: United States gdp (current prices, $ billion), 2018-22
Table 146: United States inflation, 2018-22
Table 147: United States consumer price index (absolute), 2018-22
Table 148: United States exchange rate, 2018-22
Table 149: Teva Pharmaceutical Industries Limited: key facts
Table 150: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 151: Teva Pharmaceutical Industries Limited: Key Employees
Table 152: Pfizer Inc.: key facts
Table 153: Pfizer Inc.: Annual Financial Ratios
Table 154: Pfizer Inc.: Key Employees
Table 155: Pfizer Inc.: Key Employees Continued
Table 156: Sun Pharmaceutical Industries Ltd: key facts
Table 157: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 158: Sun Pharmaceutical Industries Ltd: Key Employees
Table 159: Viatris Inc.: key facts
Table 160: Viatris Inc.: Annual Financial Ratios
Table 161: Viatris Inc.: Key Employees
Table 162: Viatris Inc.: Key Employees Continued
Table 163: Sanofi SA: key facts
Table 164: Sanofi SA: Annual Financial Ratios
Table 165: Sanofi SA: Key Employees
Table 166: Sanofi SA: Key Employees Continued
Table 167: Les Laboratoires Servier: key facts
Table 168: Les Laboratoires Servier: Key Employees
Table 169: STADA Arzneimittel AG: key facts
Table 170: STADA Arzneimittel AG: Key Employees
Table 171: Novartis AG: key facts
Table 172: Novartis AG: Annual Financial Ratios
Table 173: Novartis AG: Key Employees
Table 174: Novartis AG: Key Employees Continued
Table 175: Daiichi Sankyo Co Ltd: key facts
Table 176: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 177: Daiichi Sankyo Co Ltd: Key Employees
Table 178: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 179: Sawai Pharmaceutical Co Ltd: key facts
Table 180: Sawai Pharmaceutical Co Ltd: Key Employees
Table 181: Lupin Ltd: key facts
Table 182: Lupin Ltd: Annual Financial Ratios
Table 183: Lupin Ltd: Key Employees
Table 184: Aspen Pharmacare Holdings Ltd: key facts
Table 185: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 186: Aspen Pharmacare Holdings Ltd: Key Employees
Table 187: Apotex, Inc.: key facts
Table 188: Apotex, Inc.: Key Employees
Table 189: Grand Pharmaceutical Group Limited: key facts
Table 190: Grand Pharmaceutical Group Limited: Annual Financial Ratios
Table 191: Grand Pharmaceutical Group Limited: Key Employees
Table 192: Esteve Group: key facts
Table 193: Esteve Group: Key Employees

List of Figures
Figure 1: Global generics market value: $ million, 2017-22
Figure 2: Global generics market volume: %, 2017-22
Figure 3: Global generics market geography segmentation: % share, by value, 2022
Figure 4: Global generics market value forecast: $ million, 2022-27
Figure 5: Global generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the global generics market, 2022
Figure 7: Drivers of buyer power in the global generics market, 2022
Figure 8: Drivers of supplier power in the global generics market, 2022
Figure 9: Factors influencing the likelihood of new entrants in the global generics market, 2022
Figure 10: Factors influencing the threat of substitutes in the global generics market, 2022
Figure 11: Drivers of degree of rivalry in the global generics market, 2022
Figure 12: Asia-Pacific generics market value: $ million, 2017-22
Figure 13: Asia-Pacific generics market volume: %, 2017-22
Figure 14: Asia-Pacific generics market geography segmentation: % share, by value, 2022
Figure 15: Asia-Pacific generics market value forecast: $ million, 2022-27
Figure 16: Asia-Pacific generics market volume forecast: %, 2022-27
Figure 17: Forces driving competition in the generics market in Asia-Pacific, 2022
Figure 18: Drivers of buyer power in the generics market in Asia-Pacific, 2022
Figure 19: Drivers of supplier power in the generics market in Asia-Pacific, 2022
Figure 20: Factors influencing the likelihood of new entrants in the generics market in Asia-Pacific, 2022
Figure 21: Factors influencing the threat of substitutes in the generics market in Asia-Pacific, 2022
Figure 22: Drivers of degree of rivalry in the generics market in Asia-Pacific, 2022
Figure 23: Europe generics market value: $ million, 2017-22
Figure 24: Europe generics market volume: %, 2017-22
Figure 25: Europe generics market geography segmentation: % share, by value, 2022
Figure 26: Europe generics market value forecast: $ million, 2022-27
Figure 27: Europe generics market volume forecast: %, 2022-27
Figure 28: Forces driving competition in the generics market in Europe, 2022
Figure 29: Drivers of buyer power in the generics market in Europe, 2022
Figure 30: Drivers of supplier power in the generics market in Europe, 2022
Figure 31: Factors influencing the likelihood of new entrants in the generics market in Europe, 2022
Figure 32: Factors influencing the threat of substitutes in the generics market in Europe, 2022
Figure 33: Drivers of degree of rivalry in the generics market in Europe, 2022
Figure 34: France generics market value: $ million, 2017-22
Figure 35: France generics market volume: %, 2017-22
Figure 36: France generics market geography segmentation: % share, by value, 2022
Figure 37: France generics market value forecast: $ million, 2022-27
Figure 38: France generics market volume forecast: %, 2022-27
Figure 39: Forces driving competition in the generics market in France, 2022
Figure 40: Drivers of buyer power in the generics market in France, 2022
Figure 41: Drivers of supplier power in the generics market in France, 2022
Figure 42: Factors influencing the likelihood of new entrants in the generics market in France, 2022
Figure 43: Factors influencing the threat of substitutes in the generics market in France, 2022
Figure 44: Drivers of degree of rivalry in the generics market in France, 2022
Figure 45: Germany generics market value: $ million, 2017-22
Figure 46: Germany generics market volume: %, 2017-22
Figure 47: Germany generics market geography segmentation: % share, by value, 2022
Figure 48: Germany generics market value forecast: $ million, 2022-27
Figure 49: Germany generics market volume forecast: %, 2022-27
Figure 50: Forces driving competition in the generics market in Germany, 2022
Figure 51: Drivers of buyer power in the generics market in Germany, 2022
Figure 52: Drivers of supplier power in the generics market in Germany, 2022
Figure 53: Factors influencing the likelihood of new entrants in the generics market in Germany, 2022
Figure 54: Factors influencing the threat of substitutes in the generics market in Germany, 2022
Figure 55: Drivers of degree of rivalry in the generics market in Germany, 2022
Figure 56: Italy generics market value: $ million, 2017-22
Figure 57: Italy generics market volume: %, 2017-22
Figure 58: Italy generics market geography segmentation: % share, by value, 2022
Figure 59: Italy generics market value forecast: $ million, 2022-27
Figure 60: Italy generics market volume forecast: %, 2022-27
Figure 61: Forces driving competition in the generics market in Italy, 2022
Figure 62: Drivers of buyer power in the generics market in Italy, 2022
Figure 63: Drivers of supplier power in the generics market in Italy, 2022
Figure 64: Factors influencing the likelihood of new entrants in the generics market in Italy, 2022
Figure 65: Factors influencing the threat of substitutes in the generics market in Italy, 2022
Figure 66: Drivers of degree of rivalry in the generics market in Italy, 2022
Figure 67: Japan generics market value: $ million, 2017-22
Figure 68: Japan generics market volume: %, 2017-22
Figure 69: Japan generics market geography segmentation: % share, by value, 2022
Figure 70: Japan generics market value forecast: $ million, 2022-27
Figure 71: Japan generics market volume forecast: %, 2022-27
Figure 72: Forces driving competition in the generics market in Japan, 2022
Figure 73: Drivers of buyer power in the generics market in Japan, 2022
Figure 74: Drivers of supplier power in the generics market in Japan, 2022
Figure 75: Factors influencing the likelihood of new entrants in the generics market in Japan, 2022
Figure 76: Factors influencing the threat of substitutes in the generics market in Japan, 2022
Figure 77: Drivers of degree of rivalry in the generics market in Japan, 2022
Figure 78: Australia generics market value: $ million, 2017-22
Figure 79: Australia generics market volume: %, 2017-22
Figure 80: Australia generics market geography segmentation: % share, by value, 2022
Figure 81: Australia generics market value forecast: $ million, 2022-27
Figure 82: Australia generics market volume forecast: %, 2022-27
Figure 83: Forces driving competition in the generics market in Australia, 2022
Figure 84: Drivers of buyer power in the generics market in Australia, 2022
Figure 85: Drivers of supplier power in the generics market in Australia, 2022
Figure 86: Factors influencing the likelihood of new entrants in the generics market in Australia, 2022
Figure 87: Factors influencing the threat of substitutes in the generics market in Australia, 2022
Figure 88: Drivers of degree of rivalry in the generics market in Australia, 2022
Figure 89: Canada generics market value: $ million, 2017-22
Figure 90: Canada generics market volume: %, 2017-22
Figure 91: Canada generics market geography segmentation: % share, by value, 2022
Figure 92: Canada generics market value forecast: $ million, 2022-27
Figure 93: Canada generics market volume forecast: %, 2022-27
Figure 94: Forces driving competition in the generics market in Canada, 2022
Figure 95: Drivers of buyer power in the generics market in Canada, 2022
Figure 96: Drivers of supplier power in the generics market in Canada, 2022
Figure 97: Factors influencing the likelihood of new entrants in the generics market in Canada, 2022
Figure 98: Factors influencing the threat of substitutes in the generics market in Canada, 2022
Figure 99: Drivers of degree of rivalry in the generics market in Canada, 2022
Figure 100: China generics market value: $ million, 2017-22
Figure 101: China generics market volume: %, 2017-22
Figure 102: China generics market geography segmentation: % share, by value, 2022
Figure 103: China generics market value forecast: $ million, 2022-27
Figure 104: China generics market volume forecast: %, 2022-27
Figure 105: Forces driving competition in the generics market in China, 2022
Figure 106: Drivers of buyer power in the generics market in China, 2022
Figure 107: Drivers of supplier power in the generics market in China, 2022
Figure 108: Factors influencing the likelihood of new entrants in the generics market in China, 2022
Figure 109: Factors influencing the threat of substitutes in the generics market in China, 2022
Figure 110: Drivers of degree of rivalry in the generics market in China, 2022
Figure 111: Netherlands generics market value: $ million, 2017-22
Figure 112: Netherlands generics market volume: %, 2017-22
Figure 113: Netherlands generics market geography segmentation: % share, by value, 2022
Figure 114: Netherlands generics market value forecast: $ million, 2022-27
Figure 115: Netherlands generics market volume forecast: %, 2022-27
Figure 116: Forces driving competition in the generics market in the Netherlands, 2022
Figure 117: Drivers of buyer power in the generics market in the Netherlands, 2022
Figure 118: Drivers of supplier power in the generics market in the Netherlands, 2022
Figure 119: Factors influencing the likelihood of new entrants in the generics market in the Netherlands, 2022
Figure 120: Factors influencing the threat of substitutes in the generics market in the Netherlands, 2022
Figure 121: Drivers of degree of rivalry in the generics market in the Netherlands, 2022
Figure 122: Spain generics market value: $ million, 2017-22
Figure 123: Spain generics market volume: %, 2017-22
Figure 124: Spain generics market geography segmentation: % share, by value, 2022
Figure 125: Spain generics market value forecast: $ million, 2022-27
Figure 126: Spain generics market volume forecast: %, 2022-27
Figure 127: Forces driving competition in the generics market in Spain, 2022
Figure 128: Drivers of buyer power in the generics market in Spain, 2022
Figure 129: Drivers of supplier power in the generics market in Spain, 2022
Figure 130: Factors influencing the likelihood of new entrants in the generics market in Spain, 2022
Figure 131: Factors influencing the threat of substitutes in the generics market in Spain, 2022
Figure 132: Drivers of degree of rivalry in the generics market in Spain, 2022
Figure 133: United Kingdom generics market value: $ million, 2017-22
Figure 134: United Kingdom generics market volume: %, 2017-22
Figure 135: United Kingdom generics market geography segmentation: % share, by value, 2022
Figure 136: United Kingdom generics market value forecast: $ million, 2022-27
Figure 137: United Kingdom generics market volume forecast: %, 2022-27
Figure 138: Forces driving competition in the generics market in the United Kingdom, 2022
Figure 139: Drivers of buyer power in the generics market in the United Kingdom, 2022
Figure 140: Drivers of supplier power in the generics market in the United Kingdom, 2022
Figure 141: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2022
Figure 142: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2022
Figure 143: Drivers of degree of rivalry in the generics market in the United Kingdom, 2022
Figure 144: United States generics market value: $ million, 2017-22
Figure 145: United States generics market volume: %, 2017-22
Figure 146: United States generics market geography segmentation: % share, by value, 2022
Figure 147: United States generics market value forecast: $ million, 2022-27
Figure 148: United States generics market volume forecast: %, 2022-27
Figure 149: Forces driving competition in the generics market in the United States, 2022
Figure 150: Drivers of buyer power in the generics market in the United States, 2022
Figure 151: Drivers of supplier power in the generics market in the United States, 2022
Figure 152: Factors influencing the likelihood of new entrants in the generics market in the United States, 2022
Figure 153: Factors influencing the threat of substitutes in the generics market in the United States, 2022
Figure 154: Drivers of degree of rivalry in the generics market in the United States, 2022